Loading

JSM Clinical Case Reports

Visual Hallucinations in Parkinson Disease relates to Profession: A Case Report

Case Report | Open Access | Volume 7 | Issue 1

  • 1. Rawalpindi Medical College, Rawalpindi, Pakistan
  • 2. Department of Neurology, ShifaTameer-e-Millat University Islamabad, Pakistan
  • 3. Department of Neurological Sciences, University of Nebraska Medical Center, USA
+ Show More - Show Less
Corresponding Authors
Muhammad Atif Amer, Department of NeurologicalSciences, University of Nebraska Medical Center, Omaha, NE, USA
Abstract

Visual Hallucinations (VH) are common in Parkinson Disease (PD) and are likely related to changes in the visual pathways as shown by increased serotonergic binding and changes on structural and functional brain studies. We present a case of a retired pediatrician with PD who presented with persistent hallucinations of seeing small children in the setting of dopaminergic medication use. The content of his hallucinations was very consistent throughout. We review the literature related to visual hallucination and suggest that contents of visual hallucinations in PD are likely related to prior strong emotional visual memories including those generated through the patient’s profession.

Keywords

Parkinson disease; Parkinson disease psychosis; Visual hallucinations; Visual memory; Dopamine

Citation

Ameer MA, Khalil K, Ahmad A, Torres-Russotto DR, Bhatti D (2019) Visual Hallucinations in Parkinson Disease relates to Profession: A Case Report. JSM Clin Case Rep 7(1): 1170.

INTRODUCTION

Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting 1% of individuals older than 65 years of age, with similar prevalence across the globe [1]. The four cardinal symptoms of PD are motor, namely bradykinesia, resting tremor, rigidity and postural instability. However, PD is strongly associated with non-motor symptoms such as cognitive impairment, behavioral disturbances, autonomic instability, hallucinations, depression and sleep disorders [2]. Parkinson Disease Psychosis (PDP) is a common late-stage complication of PD with nearly 50% life time risk in this population [3]. This is characterized by presence of hallucinations or delusions, lasting more than one month in patient with a diagnosis of PD. PDP symptoms progress over time [4] and are associated with significant burden for patients and caregivers including increased hospitalization [5], increased attention by caregivers and decline in physical health [6].

Hallucinations are defined as having sensory perceptions in the absence of external sensory stimuli and can be visual, auditory, tactile, olfactory, gustatory and somatic. Visual hallucinations are by far the most common symptom in PDP [3]. Risk factors for PDP include long duration of disease, cognitive impairment, sleep-wake disturbances and use of dopaminergic agents [7]. Impairment in motor status, ocular disorders and depression are other minor risk factors [8]. Treatment for PD psychosis is complex, and includes non-pharmacological and pharmacological options. However, the long-term benefits and complications of the available therapeutics have not been ascertained [9].

Visual hallucinations in PD may be related to lack of suppression of visual association cortex from primary visual cortex due to decrease in visual input due to retinal dopamine deficiency [10,11]. Although PD medications also play a role in the production of visual hallucinations, the mechanism for this observation is still unclear [12,13]. Due to excessive activation of existing pathways, it is quite possible that hallucinations can ‘relive’ a prior visual experience. Patients have often reported seeing a deceased loved one, including deceased pets. In our experience, we have noted findings quite often related to prominent prior visual experiences which in most cases relate the work habits. Here we summarize a case report to support and discuss our hypothesis that VH in PD are commonly associated with prior visual experiences especially regarding patients’ profession.

CASE REPORT

78 years old male, retired pediatrician with a history of PD since 2006, presented to the neurology clinic in May 2015 with hallucinations. He had Idiopathic Parkinson’s Disease since 2009 and had postural imbalance with gait problems, poor posture, drooling, Rapid Eye Movement Sleep Behavior Disorder (RBD) and freezing of gait. His primary complaint, however, was visual hallucinations that started in 2011. He saw images of one or two small children playing at some distance, usually on waking up from sleep. He reported these images were sharp, colored and very vivid. These occurred 2-3 times/day, lasting for few seconds to couple of minutes and usually during the medication ON-phase. He had intact insight and hallucinations were not frightening. He had no interaction with them and they were consistently the same children. No triggers were noted and images easily disappeared by diverting the attention. In 2013 (2 years after onset of hallucinations), he started to see a man standing or sitting at some distance. Now he became disturbed and reacted to him saying “get out” and “go away”, but insight was retained most of the time. On examination, he had Hoehn and Yahr Stage 3 Parkinsonism with partial ON UPDRS-Part III score of 52, with a rare right hand typical resting tremor and mainly rigidity with akinesia. Cervical dystonia (mainly anterocollis) and drooling was noted. Other significant findings included hypometric saccades, occasional square wave jerks, mild finger to nose dysmetria with no upper motor neuron findings. He was taking Carbidopa-levodopa 25-250 mg 0.5 tablet six times daily along with Carbidopa-levodopa Extended release 50-200 mg tablet at 3 am and ropinirole 2 mg three times daily. He reported hallucinations started after ropinirole was added. After decreasing ropinirole to 4 mg daily, the hallucinations improved significantly but did not resolve. On follow up, he reported consistent improvement with decrease in frequency and he was maintained on same prescription

DISCUSSION

Different assumptions have been laid forward regarding visual hallucinations in PD such as overstimulation of mesolimbic structures with dopaminergic medications, Lewy body deposition in temporal lobe and abnormality in cortical areas involving visual cortex and visual pathway [10,11]. However most accepted hypothesis is related to impair visual processing in the setting of dopaminergic and cholinergic degeneration.

To our knowledge, Diederich NJ et al, were the first ones who proposed theory of impaired visual processing in PD patients with hallucinations in 1998. They also explained that VH in PD are due to re-emergence of previously stored percepts which normally suppressed in the presence of sufficient visual input due to retinal dopamine deficiency [10].There is evidence that 5-HT2A receptor binding is increased in PD patients with hallucinations in certain regions of the brain including the ventral visual pathway, the bilateral dorsolateral prefrontal cortex, medial orbitofrontal cortex, and insula [14]. Although PD medications also play a role in the production of visual hallucinations, the mechanism for this observation is still unclear [12,13]. Diederich and Holroyd have individually put forward the theory that visual hallucinations may be related to lack of suppression of visual association cortex from primary visual cortex due to decrease in visual input seen in PD due to retinal dopamine deficiency [10,11]. This theory was later supported by Holroyd and Wooten’s work with fMRI in PD patients with and without hallucinations that examined visual cortices as well as visual pathways. They noted enhanced activity in visual association cortex but activation deficient in primary visual cortex along with retinal dopamine deficiency in patients with hallucinations as compared to those without [11].

A voxel-based morphometry (VBM) analysis of brain Magnetic Resonance Imaging (MRI) revealed that PD patients with hallucinations, especially visual, show reduced grey matter volume in frontal, temporal and thalamic areas. Structural abnormalities to these areas can be responsible for impaired visual processing leading to visual hallucinations [15]. Grey matter volume reductions in the lingual gyrus and superior parietal lobe areas were also observed in hallucinated PD patients, which are both involved in higher visual processing.

These findings support the idea of impaired visual processing as a mechanism of visual hallucinations in PD patients.

Commonly the contents of VH are people, animals, objects, whole faces, colors, motion, scenery and sometimes vague which confirm the involvement of ventral and dorsal visual pathways responsible [8]. In our experience patients may report seeing small or little people but they are usually of adult age. Our patient, a pediatrician, hallucinated mostly about children. This raises questions as to whether these hallucinations are related to his profession or prior memories. Similar experience has been described by farmers in rural communities where they reported seeing farm animals which is an otherwise highly rare finding (personal experience and communications).In the same way, a textile artist hallucinates about colored strings lying near her (personal communication). Some other authors have reported that VH in PD patients may be related to something of importance to patients, such as seeing a pet dog which had died 5 years ago [16].

Conventional theories believe only limbic system of the medial temporal lobe is responsible for storage and processing of memories. However, Lashley’s research shows that long term memories are stored all over the cortex with respect to their stimulus after consolidation in hippocampus e.g. neuronal groups in visual cortex will store a sight memory. Recent studies support the fact that the hippocampus is only a relay center not a reservoir/storage place for long term memories. It might act as a binding area for different cortical regions that participated in the initial encoding of memory [17]. Association of visual memory storage in visual cortex and visual processing impairment in PD supports our suggestion that VH contents in PD are related to patient’s prior memories which are often related to profession and patient’s emotional attachments.

CONCLUSIONS

Current work suggests that visual hallucinations in Parkinson Disease Psychosis are associated with impairment in visual cortices and visual processing areas and we propose that these are usually consistent with prior visual memories of significant for patients and commonly relates to their professional life.

REFERENCES

1. Alexis Elbaza, James H Bowerb, Demetrius M Maraganoreb, Shannon K McDonnella, Brett J Petersona, J.Eric Ahlskogb, et al. Risk tables for parkinsonism and Parkinson’s disease. J Clin Epidemiol. 2002; 55: 25- 31.

2. Hauser RA, Biaggioni I, Hewitt LA, Vernino S. Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease. Mov Disord Clin Pract. 2018; 5: 627-634.

3. Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, et al. A 12-Year Population-Based Study of Psychosis in Parkinson Disease. Arch Neurol.2010; 67: 996-1001.

4. Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, et al. Diagnostic criteria for psychosis in Parkinson’s disease: Report of an NINDS, NIMH work group. Mov Disord.2007; 22: 1061–1068.

5. Klein C, Prokhorov T, Miniovitz A, Dobronevsky E, Rabey JM. Admission of Parkinsonian patients to a neurological ward in a community hospital. J Neural Transm. 2009; 116: 1509-1512.

6. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiverburden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006; 12, 35-41.

7. Zahodne LB, Fernandez HH. Pathophysiology and Treatment of Psychosis in Parkinson’s disease: A Review. Drugs & Aging. 2008; 25: 665-682.

8. Mosimann UP, Rowan EN, Partington CE, Collerton D, Littlewood E, O’Brien JT, et al. Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia with Lewy Bodies. Am J Geriatr Psychiatry. 2006; 14: 153-160.

9. Bhatti D, Torres-Russotto D. Pharmacological Management of Psychosis in Parkinson Disease: A Review. CDTH. 2012; 7: 151-163.

10. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson’s disease. Clin Neuropharmacol. 1998; 21: 289-295.

11. Holroyd S, Wooten GF. Preliminary FMRI Evidence of Visual System Dysfunction in Parkinson’s disease Patients With Visual Hallucinations. J Neuropsychiatry Clin Neurosci. 2006; 18: 402-404.

12. Kuzuhara S. Drug-induced psychotic symptoms in Parkinson’s disease. Problems, management and dilemma. J Neurol. 2001; 248: 28-31.

13. Banerjee AK, Falkai PG, Savidge M. Visual hallucinations in the elderly associated with the use of levodopa. Postgrad Med J. 1989; 65: 358- 361.

14. Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, et al. Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease. Arch Neurol. 2010; 67: 416-421.

15. Shin S, Lee JE, Hong JY, Sunwoo MK, Sohn YH, Lee PH. Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2012; 83: 1155- 1161.

16. Barnes,J. Visual hallucinations in Parkinson’s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001; 70: 727-733.

17. Kanthamalee S, Sripankaew K. Effect of neurobic exercise on memory enhancement in the elderly with dementia. JNEP. 2013: 4: 69.

Ameer MA, Khalil K, Ahmad A, Torres-Russotto DR, Bhatti D (2019) Visual Hallucinations in Parkinson Disease relates to Profession: A Case Report. JSM Clin Case Rep 7(1): 1170.

Received : 09 Oct 2019
Accepted : 21 Oct 2019
Published : 22 Oct 2019
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X